Appointment of liquidators (MVL)
Novartis Europharm Limited enters members' voluntary liquidation
In short: Novartis Europharm Limited (company no. 03068306) entered members' voluntary liquidation, a solvent and planned closure, according to a Appointment of liquidators (MVL) notice published in The London Gazette on 08 October 2026. The office holders are Derek Neil Hyslop (IP No. 9970); Matthew Coomber (IP No. 24430), appointed 30 September 2026. The company's business: other business support service activities not elsewhere classified.
Members appointed liquidators for several companies on 30 September 2026.
Notice details
- Company
- NOVARTIS EUROPHARM LIMITED
- Company number
- 03068306
- Nature of business
- Other business support service activities not elsewhere classified
- Company
- NOVARTIS GRIMSBY LIMITED
- Company number
- 00170180
- Nature of business
- Manufacture of dyes and pigments, Manufacture of other inorganic basic chemicals, Manufacture of plastics in primary forms, Manufacture of basic pharmaceutical products
- Company
- GYROSCOPE THERAPEUTICS LIMITED
- Company number
- 10131257
- Nature of business
- Research and experimental development on biotechnology
- Company
- GYROSCOPE THERAPEUTICS HOLDINGS LIMITED
- Company number
- 13086765
- Nature of business
- Activities of other holding companies not elsewhere classified
- Company
- ADVANCED ACCELERATOR APPLICATIONS (UK & IRELAND) LIMITED
- Company number
- 04189193
- Nature of business
- Non-specialised wholesale trade
- Registered office
- 1 More London Place, London, SE1 2AF
- Type of liquidation
- Members
- Date of appointment
- 30 September 2026
- Liquidator(s)
- Derek Neil Hyslop (IP No. 9970); Matthew Coomber (IP No. 24430)
- Appointed by
- Members
- Liquidator address
- Ernst & Young LLP, 1 More London Place, London, SE1 2AF
What this notice means
A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.
Read more: What is Liquidation?.
All notices for Novartis Europharm Limited
3 Gazette notices on record for company no. 03068306, newest first. The full history, with last filed accounts, is on the Novartis Europharm Limited company record.
- Notices to creditors (MVL) 08 Oct 2026
- Resolution for winding up (MVL) 08 Oct 2026
How does this notice affect you?
Choose what applies and we'll point you at the right next step.
A written-off invoice rarely stops at the company that failed. The supplier left short is often the next business in difficulty — and the earlier that's dealt with, the more options stay open. If NOVARTIS EUROPHARM LIMITED owed you money, it's worth checking where that leaves you.
Unpaid wages, holiday pay and statutory redundancy are claimed from the government's Redundancy Payments Service, not from K2. The insolvency practitioner named in this notice should send you a case reference — you'll need it to claim.
K2's founder has turned around UK businesses since 1990, and K2 has backed and restructured them since 2001, including buying trade and assets out of distress. These situations move in days rather than months, so if you're looking at NOVARTIS EUROPHARM LIMITED or something similar, start the conversation early.
A members' voluntary liquidation is a solvent, orderly closure — often part of retirement, a group restructure, or moving on to the next venture. K2's founder has advised UK company directors since 1990 on restructuring and what comes next. If that's on your horizon, talk to us.
Related guidance
Free, practical guides from K2 on what this kind of notice means for directors.
More liquidation notices
Frequently asked questions
Is Novartis Europharm Limited in financial difficulty?
No — this is a solvent process. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The London Gazette published a Appointment of liquidators (MVL) for Novartis Europharm Limited (company no. 03068306) on 08 October 2026.
What does a Appointment of liquidators (MVL) mean?
A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.
Who is dealing with the liquidation?
The office holders named in the notice: Derek Neil Hyslop (IP No. 9970); Matthew Coomber (IP No. 24430), appointed 30 September 2026. Creditors, employees and anyone holding goods or money belonging to the company should contact them directly, quoting the company number.
Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.